Most published evidence currently comes from laboratory and animal studies, with relatively few controlled human trials available
For instance, the ablation of striatal projections using excitotoxic lesions induced by quinolinic (QA) or ibotenic acid (IBO), and damage to the nigrostriatal dopamine (DA) system using the 6-OHDA neurotoxin
A Cochrane systematic review of NAC for COPD exacerbations (39 RCTs, n=7,436) found that NAC and other mucolytics significantly reduced the frequency of acute exacerbations (OR 0.75, 95% CI 0.62-0.92) (Poole et al., Cochrane Database Syst Rev, 2019) [43]
This is when some people may start to see more consistent weight loss
Yadav AK, Desai PR, Rai MN, Kaur R, Ganesan K, et al